Provided by Tiger Trade Technology Pte. Ltd.

Vera Therapeutics, Inc.

31.77
-1.9000-5.64%
Post-market: 32.010.2400+0.76%19:57 EDT
Volume:3.91M
Turnover:125.43M
Market Cap:2.28B
PE:-5.39
High:34.00
Open:33.22
Low:31.19
Close:33.67
52wk High:56.05
52wk Low:23.05
Shares:71.71M
Float Shares:52.39M
Volume Ratio:1.03
T/O Rate:7.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8984
EPS(LYR):-4.6644
ROE:-91.75%
ROA:-46.76%
PB:5.59
PE(LYR):-6.81

Loading ...

Feb 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Feb 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 18, 2025

Major Issues Report

Form 8-K - Current report
Dec 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2025

Major Issues Report

Form 8-K - Current report
Dec 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 26, 2025

Major Issues Report

Form 8-K - Current report
Nov 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2025

Major Issues Report

Form 8-K - Current report
Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Aug 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]